tiprankstipranks
Trending News
More News >
Molecular Partners AG (CH:MOLN)
:MOLN

Compare Molecular Partners AG (MOLN) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Molecular Partners AG
CHF3.41
CHF127.18M
-2.50
7.71%
1 Buy
0 Hold
0 Sell
Moderate Buy
Idorsia Ltd
CHF2.93
CHF791.95M
-8.17
177.43%
2 Buy
0 Hold
0 Sell
Moderate Buy
Newron Pharmaceuticals SpA
CHF16.28
$337.96M
-487.07
81.84%
1 Buy
0 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF14.82
CHF207.98M
-0.98
-2.55%
1 Buy
0 Hold
0 Sell
Moderate Buy
Xlife Sciences Ltd.
CHF22.30
CHF128.62M
4.14
18.52%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CH:MOLN
Molecular Partners AG
3.70
0.10
2.92%
CH:IDIA
Idorsia Ltd
3.14
2.03
183.97%
CH:NWRN
Newron Pharmaceuticals SpA
15.62
6.64
73.94%
CH:SANN
Santhera Pharmaceuticals Holding
14.54
-0.22
-1.49%
CH:RLF
CH:XLS
Xlife Sciences Ltd.
22.40
2.55
12.85%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts